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Abstract Calcium phosphate ceramics, commonly
applied as bone graft substitutes, are a natural choice of
scaffolding material for bone tissue engineering. Evidence
shows that the chemical composition, macroporosity and
microporosity of these ceramics influences their behavior
as bone graft substitutes and bone tissue engineering
scaffolds but little has been done to optimize these
parameters. One method of optimization is to place focus
on a particular parameter by normalizing the influence, as
much as possible, of confounding parameters. This is dif-
ficult to accomplish with traditional fabrication techniques.
In this study we describe a design based rapid prototyping
method of manufacturing scaffolds with virtually identical
macroporous architectures from different calcium phos-
phate ceramic compositions. Beta-tricalcium phosphate,
hydroxyapatite (at two sintering temperatures) and biphasic
calcium phosphate scaffolds were manufactured. The
macro- and micro-architectures of the scaffolds were
characterized as well as the influence of the manufacturing
method on the chemistries of the calcium phosphate com-
positions. The structural characteristics of the resulting
scaffolds were remarkably similar. The manufacturing
process had little influence on the composition of the
materials except for the consistent but small addition of, or
increase in, a beta-tricalcium phosphate phase. Among
other applications, scaffolds produced by the method
described provide a means of examining the influence of
different calcium phosphate compositions while confi-
dently excluding the influence of the macroporous structure
of the scaffolds.
1 Introduction
Calcium phosphate ceramics have seen extensive clinical
application as synthetic bone fillers and graft extenders
[1–3]. The biocompatibility as well as osteoconductive
and osteoinductive properties of these ceramics have been
well documented [4–12]. Bone Tissue Engineering
research has capitalized on these qualities, making porous
calcium phosphate ceramics a popular choice of scaffold
[13–16].
Porous ceramics for medical applications have been
manufactured for decades using a variety of traditional
methods. Conversion of natural structures, such as coral
[17, 18], and trabecular bone [19, 20] yield porous
ceramics with organic architectures that appear very sim-
ilar to that of the bone that is being replaced. Synthetic
manufacturing methods such as foaming [21–23], dual-
phase mixing [24] and the slip-casting of polymer foams
and particles [25–27], may also be used to produce porous
ceramics. However, conversion and synthetic techniques
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result in highly complex macroporous structures that are
difficult to define quantitatively. Despite the complex nat-
ure of the porous ceramics produced by conventional
means, quite some information is available regarding the
influence the porous structure has on osteoconduction [28–
35], BMP induced osteogenesis [26, 36–38], and osteoin-
duction [11, 39].
Rapid prototyping (RP), also termed free form fabrica-
tion, refers to a variety of technologies capable of pro-
ducing three-dimensional (3D) physical constructs directly
from 3D computer aided models. In recent years, rapid
prototyping has been proposed for the production of both
scaffolds with controlled porous architectures [40–42] as
well as porous implants with patient specific geometries
[43–45]. Several rapid prototyping techniques have been
developed to produce ceramic scaffolds for bone tissue
engineering research [46–49].
The aim of the current study was to produce porous
ceramic scaffolds from different calcium phosphate mate-
rials with sufficiently similar macroporous architectures as
to be able to reasonably eliminate the macroporous archi-
tecture as a confounding variable in future tissue engi-
neering studies. The scaffolds were produced by casting
four different calcium phosphate materials into identical
molds produced using a rapid prototyping technique. The
resulting macroporous structures as well as the chemistry
before and after manufacture were evaluated.
2 Materials and methods
2.1 Scaffold design and mold fabrication
Scaffolds were designed and molds fabricated as described
previously [49]. Briefly, the scaffolds specifications called
for an interconnecting network of 400 lm square cross-
section channels oriented along the orthogonal axes and
separated from each other and the exterior by 400 lm. Six,
four, and three channels were incorporated in the X, Y, and
Z axis directions, resulting in overall design dimensions of
5.2 9 3.6 9 2.8 mm, respectively. A schematic of such a
scaffold is shown in Fig. 1. Molds, with cavities for the
production of six scaffolds each, were designed using
the Rhinoceros computer aided design software (Robert
McNeel & Associates, USA). The mold model was
scaled to account for shrinkage of approximately 20%
during thermal processing demonstrated previously by our
hydroxyapatite ceramics. This resulted in pre-thermal
processing scaffold dimensions of 6.5 9 4.5 9 3.5 mm in
the X, Y, and Z axis directions. Multiple copies of the mold
were produced using a ModelMaker II rapid prototyping
system (Solidscape Inc., USA).
2.2 Ceramic slurries
Ceramic scaffolds were manufactured to achieve four
conditions through combinations of calcium phosphate
ceramic compositions and sintering temperatures as out-
lined in Table 1. Hydroxyapatite powder (HA, Merck,
Germany), beta-tricalcium phosphate powder (TCP,
Merck, Germany) and biphasic calcium phosphate powder
(BCP, wt% 85/15 HA/TCP, IsoTis SA) were obtained
commercially. The HA and TCP raw powders were cal-
cined by heating from ambient to 900C at a rate of 100C/
hour and then cooled naturally with no dwell period.
Aqueous slurries of HA, TCP, and BCP powders were
prepared as previously described for the production of cast
plates [50]. In brief, the slurry components detailed below
were slowly admixed until a homogenous blend was
achieved. The HA and TCP slurries consisted of 67.1 wt%
calcined HA powder, 28.6 wt% demineralized water, 2.6
wt% ammonia solution (25%, Merck), 1.5 wt% defloccu-
lant (Dolapix, Aschimmer & Schwarz GmbH, Germany).
Once a homogeneous blend was obtained, a CMC binder
was added (0.15 wt%, Pomosin BV, The Netherlands) to
the HA slurry and the slurry further mixed until homoge-
neous. The BCP slurry consisted of 56.4 wt% ceramic
powder, 37.6 wt% demineralized water, 3.9 wt% ammonia
solution, and 2.1 wt% deflocculant. No binder was added to
the TCP and BCP slurries. All slurries were stored in
covered beakers until there use within the same day.
2.3 Scaffold fabrication
The molds were filled using a simple vacuum device [49].
Millex-GV filter units (25 mm, Millipore S.A., France)
were divided in half and the filter paper removed to expose
Fig. 1 Schematic of the designed scaffolds including the three
orthogonal planes used to define the scaffold surfaces
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the perforated interior surface. The open face of a mold
was carefully placed against the interior surface of a filter
half and secured by circumferentially wrapping with wax
laboratory film. The mold/filter constructs were attached to
50 ml syringes and flushed with demineralized water.
During casting, the beakers containing slurry were placed
on a Porex vibrating table (Renfert, Germany). This
assisted in mold filling by imparting shear energy and thus
lowering the viscosity of the pseudoplastic (shear thinning)
slurries. The molds were filled by submerging the open
face of each mold in slurry and then drawing vacuum
pressure using the syringe. The molds were then placed on
a sheet wax laboratory film and the syringes and filter
halves removed. The molds were allowed to air dry over-
night at room temperature and were then further dried for
24 h at 50C in air. Excess slurry from each ceramic
composition was processed identically to the molded
ceramics to serve as controls when examining material
chemistry and to further examine the previously observed
influence of the rapid prototyping wax on the material
composition [49].
Debinding and sintering of the ceramics were performed
in two steps in a high temperature furnace (Nabertherm
1400, Germany). Debinding of all ceramics was performed
by heating at a rate of 0.5C/minute to 400C and then
cooling naturally with no dwell period. The ceramics were
then sintered using a 600 min heating phase with a
480 min dwell period at the final sintering temperature
followed by natural cooling. One set of HA scaffold was
sintered at 1250C, designate HA h, while a sintering
temperature of 1150C was used for a second set of HA
scaffolds, designate HA l, as well as all of the TCP and
BCP scaffolds. Excess ceramic, occasionally present on the
scaffold faces corresponding to the open sides of the molds,
was removed using a rotary polisher (LaboPol-5, Struers,
Denmark) with 1200 grit waterproof silicon carbide paper
(Struers). The ceramics were cleaned by ultrasound for
15 min each in acetone, 100% ethanol and deionized water,
and then dried in air at 50C.
2.4 Scaffold characterization
The exterior scaffold dimensions were measured using a
digital caliper (CD-15C, Mitutoyo Ltd., UK) and used to
calculate the shrinkage resulting from the combined
debinding and sintering processes. Scanning electron
microscopy (SEM, XL 30 ESEM-FEG, Philips, The Nether-
lands) was used to examine the macro-architecture and
surface micro-structure of the scaffolds. The dimensions of
the macroporosity were measured in each of the orthogonal
planes (Fig. 1). The apparent porosity of the scaffolds was
determined by comparing the apparent density of each
scaffold (dry weight/measured volume) and the theoretical
density of HA (3.156 g/cm3) [39], TCP (3.14 g/cm3), and
BCP (85% HA, 15% TCP). The chemistry of raw ceramic
powder, calcined ceramic powder, non-molded sintered
ceramic and molded scaffolds were evaluated by X-ray dif-
fraction (XRD, Miniflex, Rigaku, Japan). Finally, the
potential contamination of the ceramics by residues from the
wax mold material was investigated by performing energy-
dispersive X-ray spectroscopy (EDX, XL 30 ESEM-FEG,
Philips, The Netherlands) on the surface of cast and non-cast
(not exposed to wax mold material) ceramics specimens.
3 Results
The manufacturing process resulted in scaffolds with
remarkably similar structural appearances (Fig. 2). Scaf-
fold dimensions, shrinkage, volume, weight and apparent
Table 1 Scaffold dimensions, shrinkage, volume, weight, and apparent porosity of scaffolds compared to the solids in slurry and sintering
temperature during manufacturing
Material Solids in
slurry (wt%)
Sintering
temp. (C)
Exterior dimensions
(mm ± SD)
Srinkage (from
‘as molded’, %)
Volume
(mm3 ± SD)
Weight
(mg ± SD)
Apparent porosity
(% ± SD)
HA h 67.1 1250 x: 5.05 ± 0.05 x: 22.35 47.92 ± 0.87 76.16 ± 2.89 49.65 ± 1.76
y: 3.48 ± 0.03 y: 22.68
z: 2.73 ± 0.03
HA l 67.1 1150 x: 6.14 ± 0.05 x: 5.48 84.63 ± 3.17 73.82 ± 5.40 72.39 ± 1.27
y: 4.23 ± 0.13 y: 6.04
z: 3.26 ± 0.11
BCP 56.4 1150 x: 5.45 ± 0.05 x: 16.21 58.96 ± 1.38 48.86 ± 2.33 73.72 ± 1.03
y: 3.73 ± 0.06 y: 7.86
z: 2.90 ± 0.06
TCP 67.1 1150 x: 6.05 ± 0.04 x: 6.88 80.53 ± 3.05 69.49 ± 4.54 72.54 ± 1.10
y: 4.15 ± 0.13 y: 7.86
z: 3.21 ± 0.09
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porosity values are summarized in Table 1. The high sin-
tering temperature HA scaffolds exhibited the greatest
shrinkage and lowest apparent porosity. The BCP scaffolds
also demonstrated considerable shrinkage but maintained a
high apparent porosity similar to the low sintering tem-
perature HA and TCP scaffolds. The low sintering tem-
perature HA and TCP scaffolds exhibited the lowest
shrinkage. Shrinkage in the z-direction and volumetric
shrinkage were not calculated since the respective surfaces
were manually polished to remove excess ceramic and
therefore do not represent the ‘as cast’ properties. In order
to evaluate whether the various treatments influenced the
ratio of macroporosity to total porosity, computer models
of the porous scaffolds were created using the measured
exterior and macropore dimensions in Tables 1 and 2,
respectively. These computer models were used to calcu-
late the approximate volume of the macroporosity. Table 3
shows the volumes approximated by the computer models
for the various treatments and compares the resulting
macroporosity to the measured apparent porosity.
SEM images of the resulting scaffolds are shown in
Fig. 3. These scaffolds are discussed in the following text
using the axes and orthogonal planes depicted in Fig. 1. A
distinctive texture of parallel ridges and valleys was
observed in SEM micrographs on all vertical scaffold
surfaces, i.e., surfaces parallel to the x–z and y–z planes.
This texture is an impression of the rapid prototyped mold
and a consequence of the layer-by-layer manufacturing of
the mold. The cross-sectional geometry of the channels was
dependant upon the orientation of the channel. Channels
running in the x- and y-directions were square in cross
section with textured vertical surfaces and smooth hori-
zontal surfaces. Channels running in the z-direction were
rounded with no apparent texturing. Again, this is a con-
sequence of the mold manufacturing process.
The surface microporosity of the scaffolds, as observed
by SEM, varied with material composition and sintering
temperature (Fig. 3). The BCP scaffolds exhibited a
PCBhAH PCTlAH
Fig. 2 The four ceramic
compositions all in 25 well
plates. Note the similarity of the
scaffold structures and the
differences in the scaffold
colors
Table 2 Pore dimensions by orthogonal plane (Fig. 1)
Material Pore dimensions (lm ± SD)
x–y plane x–z plane y–z plane
HA h x: 286 ± 15 x: 353 ± 28 y: 394 ± 24
y: 280 ± 16 z: 339 ± 17 z: 376 ± 30
HA l x: 414 ± 44 x: 470 ± 37 y: 484 ± 29
y: 416 ± 34 z: 496 ± 21 z: 486 ± 27
BCP x: 366 ± 24 x: 444 ± 47 y: 432 ± 37
y: 377 ± 18 z: 433 ± 20 z: 414 ± 42
TCP x: 405 ± 43 x: 460 ± 36 y: 474 ± 29
y: 408 ± 33 z: 486 ± 21 z: 476 ± 26
Table 3 Scaffold volumes and macroporosity calculated form computer models compared to the measured total apparent porosity and other
porosity (difference between macro and apparent porosity)
Material Total
volume (mm3)
Material
volume (mm3)
Pole
volume (mm3)
Macro-
porosity (%)
Apparent
porosity (%)
Other
porosity (%)
HA h 47.98 31.78 16.19 33.75 49.65 15.90
HA l 84.67 50.19 34.48 40.72 72.39 31.67
BCP 58.95 34.82 24.14 40.94 73.72 32.78
TCP 80.60 48.08 32.51 40.34 72.54 32.20
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spectrum of surface microporosity features from approxi-
mately 1 to 10 lm in size. The surface features of the low
sintering temperature HA scaffolds were similar to the
BCP with perhaps somewhat less and smaller surface
microporosity, approximately 0.5–5 lm. The high sinter-
ing temperature HA scaffolds exhibited smoother surfaces
with very little microporosity. The TCP material, in con-
trast to the other materials sintered at low temperatures,
appeared very similar to the high sintering temperature HA
with very little surface microporosity.
The XRD patterns for the different ceramic chemistries,
shown in Fig. 4, were generally as expected. Figure 4a
shows the patterns for the HA ceramic raw powder, cal-
cined powder, non-molded material sintered at 1150C,
scaffolds sintered at 1150C, non-molded material sintered
at 1250C, and scaffolds sintered at 1150C. Several peaks
associated with TCP formation were observed in the pat-
terns for the cast HA scaffold materials at both the 1150
and 1250C sintering temperatures (vertical lines in
Fig. 4a). The BCP ceramics also demonstrated these TCP
peaks in the cast scaffolds (Fig. 4b, vertical lines). The
TCP ceramics exhibited changes, relative to the raw
powder, that were consistent with the calcination and sin-
tering process temperatures (Fig. 4c). The XRD patterns
for the four scaffold conditions are shown in Fig. 5 for
clarity. EDX of the surfaces of both cast and non-cast
ceramic specimens showed identical spectra consistent
with the calcium phosphate materials. There was no evi-
dence of contamination from the wax mold material.
4 Discussion and conclusions
The present study demonstrates the application of Com-
puter Aided Design and Rapid Prototyping technologies for
the production of ceramic scaffolds from different chem-
istries but with defined, virtually identical, macro-
architectures. Other than producing macroporosities with
pore dimension in the range suggested in the literature for
osteoconduction, i.e., between 50 and 500 mm [4, 28, 30,
31, 34], we did not attempt to produce optimal or ideal
porous structures. The purpose of this study was to
Fig. 3 SEM micrographs of the four scaffold materials. Rows top to
bottom HA h, HA l, BCP, and TCP. First column Perspective view of
scaffolds at 509 magnification (bar 50 lm). Second column Scaffold
structures at 1009 magnification (bar 200 lm). Note the regular
surface texture on the scaffolds. Third column Scaffold pores at 1509
magnification (bar 200 lm). Fourth column Scaffold surfaces at
10009 magnification (bar 20 lm)
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manufacture porous scaffolds in which the macroporous
architecture was designed and sufficiently similar to be
able to reasonable exclude the macroporous architecture
as a confounding variable in future research studies. The
material chemistries and thermal processing methods
employed in this study were chosen to provide continu-
ity with materials used in past and ongoing research
[49–54].
HA
Angle
Scaffold 1250
Non-Molded 1250
Scaffold 1150
Non-molded 1150
Calcined Powder
Raw Powder
BCP
Angle
Scaffold
Calcined Powder
Raw Powder
TCP
25 27 29 31 33 35 37 39 41 43 45
25 27 29 31 33 35 37 39 41 43 45
25 27 29 31 33 35 37 39 41 43 45
Angle
Scaffold
Calcined Powder
Raw Powder
a
b
c 
Fig. 4 XRD patterns of a HA h
(1250) and HA l (1150), b BCP,
and c TCP. Shown are XRD
patterns of the raw powder,
calcined powder and molded
ceramics (scaffolds). XRD
patterns of non-molded
ceramics are also shown in
(a) for the HA h (1250) and HA
l (1150) materials. Vertical
dotted lines indicate additional
peaks associated with beta-TCP
formation that are only present
in the molded specimens
(scaffolds)
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Although the visual appearance of the scaffolds was
similar with regard to structure, there were differences in
shrinkage and therefore the macroporous dimensions. As
expected from our previous work, a sintering temperature of
1250C resulted in a shrinkage of just over 22% for the HA
material compared to approximately 6% shrinkage for HA
and TCP sintered at 1150C. The relatively large shrinkage
of 16–17% for the BCP scaffolds, also sintered at 1150C,
can almost completely be accounted for by the lower solids
loading of the BCP slurry (56.4 wt%) compared to the HA
and TCT slurries (67.1 wt%). The lower solids loading was
necessary to achieve appropriate rheological properties for
the casting of scaffolds from slurries of the non-calcined
BCP powder. Interestingly, the apparent porosity of BCP
scaffolds was very similar to the TCP and low sintering
temperature HA scaffolds despite the much higher shrink-
age (Table 2). Comparing the porosity resulting from the
measured macroporous structure to the total apparent
porosity, Table 3, reveals that the a much greater proportion
of the apparent porosity of the high sintering temperature
HA is likely due to the macroporosity compared to the
lower sintering temperature materials. This indicated
greater densification due to the higher sintering tempera-
ture. The BCP, TCP and low sintering temperature HA all
had similar proportions of macroporosity despite the much
higher shrinkage of the BCP material.
The texture exhibited on the vertical surfaces of
the scaffold (Fig. 1), as well as the rounded nature of the
macropores in the z-direction, are a consequence of the
rapid prototyping technique used to manufacture the molds.
This technique jets molten droplets of wax material, which
flatten and spread when they strike the surface, to build
each layer of the molds. As molds are built up vertically
layer by layer, this results in a texture on the vertical sur-
faces (x–z and y–z planes) which is subsequently cast into
the ceramic. The rounded corners of channels running in
the z-direction (cross-sections parallel to the x–y plane)
result from the coalescing or pooling of adjacent droplets
prior to solidification, resulting in rounding of both inside
and outside corners within the printed layers. These roun-
ded mold corners are then cast into the resulting ceramic
scaffolds and observed in channels running parallel to the
z-direction.
Compositional analyses by XRD were largely as
expected. The XRD patterns for the HA and BCP scaffolds
indicated that a TCP phase had been introduced. Since the
XRD patterns of the non-molded specimens did not show
the TCP phase and the molded and non-molded materials
were treated identically with the exception of the molding
process, it is likely that the presence of TCP phase after
molding results from the exposure of the HA and BCP
materials to the wax mold material itself, despite elemental
analysis of cast and non-cast specimens demonstrated
there was no direct contamination of the ceramics by the
mold material. The mechanism for this is not clear but is
consistent with our previous findings for HA materials
[49].
In conclusion, we have demonstrated a rapid prototyping
method for fabricating ceramic scaffolds with virtually
identical, 3-dimensional, macroporous architectures from
different calcium phosphate ceramics. Scaffolds produced
by this method will not only enhance research aimed at
optimizing macroporous architectures and material com-
positions but will improve many other aspects of tissue
engineering research by eliminate differences in macro-
porous structure as a confounding variable.
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Fig. 5 XRD patterns of the four
scaffold materials. Vertical
dotted lines indicate beta-TCP
peaks which form in the HA and
BCP material as a result of the
molding process
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